[Efficacy and safety of BTK inhibitor, venetoclax and rituximab in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma].
Year: 2023
Type: article
Source: PubMed Central
Institution: Jiangsu Province Hospital
Language: Chinese
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4382011190
